世界のジカウイルス感染治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Zika Virus Infection Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5048
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ジカウイルス感染治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射剤）、用途別市場規模（病院、在宅医療、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ジカウイルス感染治療薬の市場動向
・企業の競争状況、市場シェア
・ジカウイルス感染治療薬の種類別市場規模と予測2016-2027（経口剤、注射剤）
・ジカウイルス感染治療薬の用途別市場規模と予測2016-2027（病院、在宅医療、クリニック、その他）
・ジカウイルス感染治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・ジカウイルス感染治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ジカウイルス感染治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ジカウイルス感染治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・ジカウイルス感染治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Emergent BioSolutions、Valneva、Moderna、Novavax、Johnson & Johnson、Themis Bioscience、Sanofi、IMV、Takeda Pharmaceutical、CaroGen、GeoVax、Tychan、Inovio Pharmaceuticals）
・結論

It is used to treat various uncomfortable symptoms caused by zika virus infection.

Market Analysis and Insights: Global Zika Virus Infection Drug Market
The global Zika Virus Infection Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Zika Virus Infection Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Zika Virus Infection Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Zika Virus Infection Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Zika Virus Infection Drug market.

Global Zika Virus Infection Drug Scope and Market Size
Zika Virus Infection Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Zika Virus Infection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hospital
Homecare
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Emergent BioSolutions
Valneva
Moderna
Novavax
Johnson & Johnson
Themis Bioscience
Sanofi
IMV
Takeda Pharmaceutical
CaroGen
GeoVax
Tychan
Inovio Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zika Virus Infection Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Zika Virus Infection Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Zika Virus Infection Drug Market Perspective (2016-2027)
2.2 Zika Virus Infection Drug Growth Trends by Regions
2.2.1 Zika Virus Infection Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Zika Virus Infection Drug Historic Market Share by Regions (2016-2021)
2.2.3 Zika Virus Infection Drug Forecasted Market Size by Regions (2022-2027)
2.3 Zika Virus Infection Drug Industry Dynamic
2.3.1 Zika Virus Infection Drug Market Trends
2.3.2 Zika Virus Infection Drug Market Drivers
2.3.3 Zika Virus Infection Drug Market Challenges
2.3.4 Zika Virus Infection Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Zika Virus Infection Drug Players by Revenue
3.1.1 Global Top Zika Virus Infection Drug Players by Revenue (2016-2021)
3.1.2 Global Zika Virus Infection Drug Revenue Market Share by Players (2016-2021)
3.2 Global Zika Virus Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Zika Virus Infection Drug Revenue
3.4 Global Zika Virus Infection Drug Market Concentration Ratio
3.4.1 Global Zika Virus Infection Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zika Virus Infection Drug Revenue in 2020
3.5 Zika Virus Infection Drug Key Players Head office and Area Served
3.6 Key Players Zika Virus Infection Drug Product Solution and Service
3.7 Date of Enter into Zika Virus Infection Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Zika Virus Infection Drug Breakdown Data by Type
4.1 Global Zika Virus Infection Drug Historic Market Size by Type (2016-2021)
4.2 Global Zika Virus Infection Drug Forecasted Market Size by Type (2022-2027)

5 Zika Virus Infection Drug Breakdown Data by Application
5.1 Global Zika Virus Infection Drug Historic Market Size by Application (2016-2021)
5.2 Global Zika Virus Infection Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Zika Virus Infection Drug Market Size (2016-2027)
6.2 North America Zika Virus Infection Drug Market Size by Type
6.2.1 North America Zika Virus Infection Drug Market Size by Type (2016-2021)
6.2.2 North America Zika Virus Infection Drug Market Size by Type (2022-2027)
6.2.3 North America Zika Virus Infection Drug Market Size by Type (2016-2027)
6.3 North America Zika Virus Infection Drug Market Size by Application
6.3.1 North America Zika Virus Infection Drug Market Size by Application (2016-2021)
6.3.2 North America Zika Virus Infection Drug Market Size by Application (2022-2027)
6.3.3 North America Zika Virus Infection Drug Market Size by Application (2016-2027)
6.4 North America Zika Virus Infection Drug Market Size by Country
6.4.1 North America Zika Virus Infection Drug Market Size by Country (2016-2021)
6.4.2 North America Zika Virus Infection Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Zika Virus Infection Drug Market Size (2016-2027)
7.2 Europe Zika Virus Infection Drug Market Size by Type
7.2.1 Europe Zika Virus Infection Drug Market Size by Type (2016-2021)
7.2.2 Europe Zika Virus Infection Drug Market Size by Type (2022-2027)
7.2.3 Europe Zika Virus Infection Drug Market Size by Type (2016-2027)
7.3 Europe Zika Virus Infection Drug Market Size by Application
7.3.1 Europe Zika Virus Infection Drug Market Size by Application (2016-2021)
7.3.2 Europe Zika Virus Infection Drug Market Size by Application (2022-2027)
7.3.3 Europe Zika Virus Infection Drug Market Size by Application (2016-2027)
7.4 Europe Zika Virus Infection Drug Market Size by Country
7.4.1 Europe Zika Virus Infection Drug Market Size by Country (2016-2021)
7.4.2 Europe Zika Virus Infection Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Zika Virus Infection Drug Market Size (2016-2027)
8.2 Asia-Pacific Zika Virus Infection Drug Market Size by Type
8.2.1 Asia-Pacific Zika Virus Infection Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Zika Virus Infection Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Zika Virus Infection Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Zika Virus Infection Drug Market Size by Application
8.3.1 Asia-Pacific Zika Virus Infection Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Zika Virus Infection Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Zika Virus Infection Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Zika Virus Infection Drug Market Size by Region
8.4.1 Asia-Pacific Zika Virus Infection Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Zika Virus Infection Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Zika Virus Infection Drug Market Size (2016-2027)
9.2 Latin America Zika Virus Infection Drug Market Size by Type
9.2.1 Latin America Zika Virus Infection Drug Market Size by Type (2016-2021)
9.2.2 Latin America Zika Virus Infection Drug Market Size by Type (2022-2027)
9.2.3 Latin America Zika Virus Infection Drug Market Size by Type (2016-2027)
9.3 Latin America Zika Virus Infection Drug Market Size by Application
9.3.1 Latin America Zika Virus Infection Drug Market Size by Application (2016-2021)
9.3.2 Latin America Zika Virus Infection Drug Market Size by Application (2022-2027)
9.3.3 Latin America Zika Virus Infection Drug Market Size by Application (2016-2027)
9.4 Latin America Zika Virus Infection Drug Market Size by Country
9.4.1 Latin America Zika Virus Infection Drug Market Size by Country (2016-2021)
9.4.2 Latin America Zika Virus Infection Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Zika Virus Infection Drug Market Size (2016-2027)
10.2 Middle East & Africa Zika Virus Infection Drug Market Size by Type
10.2.1 Middle East & Africa Zika Virus Infection Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Zika Virus Infection Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Zika Virus Infection Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Zika Virus Infection Drug Market Size by Application
10.3.1 Middle East & Africa Zika Virus Infection Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Zika Virus Infection Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Zika Virus Infection Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Zika Virus Infection Drug Market Size by Country
10.4.1 Middle East & Africa Zika Virus Infection Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Zika Virus Infection Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Company Details
11.1.2 Emergent BioSolutions Business Overview
11.1.3 Emergent BioSolutions Zika Virus Infection Drug Introduction
11.1.4 Emergent BioSolutions Revenue in Zika Virus Infection Drug Business (2016-2021)
11.1.5 Emergent BioSolutions Recent Development
11.2 Valneva
11.2.1 Valneva Company Details
11.2.2 Valneva Business Overview
11.2.3 Valneva Zika Virus Infection Drug Introduction
11.2.4 Valneva Revenue in Zika Virus Infection Drug Business (2016-2021)
11.2.5 Valneva Recent Development
11.3 Moderna
11.3.1 Moderna Company Details
11.3.2 Moderna Business Overview
11.3.3 Moderna Zika Virus Infection Drug Introduction
11.3.4 Moderna Revenue in Zika Virus Infection Drug Business (2016-2021)
11.3.5 Moderna Recent Development
11.4 Novavax
11.4.1 Novavax Company Details
11.4.2 Novavax Business Overview
11.4.3 Novavax Zika Virus Infection Drug Introduction
11.4.4 Novavax Revenue in Zika Virus Infection Drug Business (2016-2021)
11.4.5 Novavax Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Zika Virus Infection Drug Introduction
11.5.4 Johnson & Johnson Revenue in Zika Virus Infection Drug Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Themis Bioscience
11.6.1 Themis Bioscience Company Details
11.6.2 Themis Bioscience Business Overview
11.6.3 Themis Bioscience Zika Virus Infection Drug Introduction
11.6.4 Themis Bioscience Revenue in Zika Virus Infection Drug Business (2016-2021)
11.6.5 Themis Bioscience Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Zika Virus Infection Drug Introduction
11.7.4 Sanofi Revenue in Zika Virus Infection Drug Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 IMV
11.8.1 IMV Company Details
11.8.2 IMV Business Overview
11.8.3 IMV Zika Virus Infection Drug Introduction
11.8.4 IMV Revenue in Zika Virus Infection Drug Business (2016-2021)
11.8.5 IMV Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Zika Virus Infection Drug Introduction
11.9.4 Takeda Pharmaceutical Revenue in Zika Virus Infection Drug Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 CaroGen
11.10.1 CaroGen Company Details
11.10.2 CaroGen Business Overview
11.10.3 CaroGen Zika Virus Infection Drug Introduction
11.10.4 CaroGen Revenue in Zika Virus Infection Drug Business (2016-2021)
11.10.5 CaroGen Recent Development
11.11 GeoVax
11.11.1 GeoVax Company Details
11.11.2 GeoVax Business Overview
11.11.3 GeoVax Zika Virus Infection Drug Introduction
11.11.4 GeoVax Revenue in Zika Virus Infection Drug Business (2016-2021)
11.11.5 GeoVax Recent Development
11.12 Tychan
11.12.1 Tychan Company Details
11.12.2 Tychan Business Overview
11.12.3 Tychan Zika Virus Infection Drug Introduction
11.12.4 Tychan Revenue in Zika Virus Infection Drug Business (2016-2021)
11.12.5 Tychan Recent Development
11.13 Inovio Pharmaceuticals
11.13.1 Inovio Pharmaceuticals Company Details
11.13.2 Inovio Pharmaceuticals Business Overview
11.13.3 Inovio Pharmaceuticals Zika Virus Infection Drug Introduction
11.13.4 Inovio Pharmaceuticals Revenue in Zika Virus Infection Drug Business (2016-2021)
11.13.5 Inovio Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Zika Virus Infection Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Zika Virus Infection Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Zika Virus Infection Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Zika Virus Infection Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Zika Virus Infection Drug Market Share by Regions (2016-2021)
Table 8. Global Zika Virus Infection Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Zika Virus Infection Drug Market Share by Regions (2022-2027)
Table 10. Zika Virus Infection Drug Market Trends
Table 11. Zika Virus Infection Drug Market Drivers
Table 12. Zika Virus Infection Drug Market Challenges
Table 13. Zika Virus Infection Drug Market Restraints
Table 14. Global Zika Virus Infection Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Zika Virus Infection Drug Market Share by Players (2016-2021)
Table 16. Global Top Zika Virus Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zika Virus Infection Drug as of 2020)
Table 17. Ranking of Global Top Zika Virus Infection Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Zika Virus Infection Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Zika Virus Infection Drug Product Solution and Service
Table 21. Date of Enter into Zika Virus Infection Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Zika Virus Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Zika Virus Infection Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Zika Virus Infection Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Zika Virus Infection Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Zika Virus Infection Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Zika Virus Infection Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Zika Virus Infection Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Zika Virus Infection Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Zika Virus Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Zika Virus Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Zika Virus Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Zika Virus Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Zika Virus Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Zika Virus Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Zika Virus Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Zika Virus Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Zika Virus Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Zika Virus Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Zika Virus Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Zika Virus Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Zika Virus Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Zika Virus Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Zika Virus Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Zika Virus Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Zika Virus Infection Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Zika Virus Infection Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Zika Virus Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Zika Virus Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Zika Virus Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Zika Virus Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Zika Virus Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Zika Virus Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Zika Virus Infection Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Zika Virus Infection Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Zika Virus Infection Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Zika Virus Infection Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Zika Virus Infection Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Zika Virus Infection Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Emergent BioSolutions Company Details
Table 62. Emergent BioSolutions Business Overview
Table 63. Emergent BioSolutions Zika Virus Infection Drug Product
Table 64. Emergent BioSolutions Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 65. Emergent BioSolutions Recent Development
Table 66. Valneva Company Details
Table 67. Valneva Business Overview
Table 68. Valneva Zika Virus Infection Drug Product
Table 69. Valneva Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 70. Valneva Recent Development
Table 71. Moderna Company Details
Table 72. Moderna Business Overview
Table 73. Moderna Zika Virus Infection Drug Product
Table 74. Moderna Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 75. Moderna Recent Development
Table 76. Novavax Company Details
Table 77. Novavax Business Overview
Table 78. Novavax Zika Virus Infection Drug Product
Table 79. Novavax Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 80. Novavax Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Zika Virus Infection Drug Product
Table 84. Johnson & Johnson Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Themis Bioscience Company Details
Table 87. Themis Bioscience Business Overview
Table 88. Themis Bioscience Zika Virus Infection Drug Product
Table 89. Themis Bioscience Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 90. Themis Bioscience Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Zika Virus Infection Drug Product
Table 94. Sanofi Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. IMV Company Details
Table 97. IMV Business Overview
Table 98. IMV Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 99. IMV Recent Development
Table 100. Takeda Pharmaceutical Company Details
Table 101. Takeda Pharmaceutical Business Overview
Table 102. Takeda Pharmaceutical Zika Virus Infection Drug Product
Table 103. Takeda Pharmaceutical Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 104. Takeda Pharmaceutical Recent Development
Table 105. CaroGen Company Details
Table 106. CaroGen Business Overview
Table 107. CaroGen Zika Virus Infection Drug Product
Table 108. CaroGen Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 109. CaroGen Recent Development
Table 110. GeoVax Company Details
Table 111. GeoVax Business Overview
Table 112. GeoVax Zika Virus Infection Drug Product
Table 113. GeoVax Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 114. GeoVax Recent Development
Table 115. Tychan Company Details
Table 116. Tychan Business Overview
Table 117. Tychan Zika Virus Infection Drug Product
Table 118. Tychan Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 119. Tychan Recent Development
Table 120. Inovio Pharmaceuticals Company Details
Table 121. Inovio Pharmaceuticals Business Overview
Table 122. Inovio Pharmaceuticals Zika Virus Infection Drug Product
Table 123. Inovio Pharmaceuticals Revenue in Zika Virus Infection Drug Business (2016-2021) & (US$ Million)
Table 124. Inovio Pharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Zika Virus Infection Drug Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Zika Virus Infection Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Homecare Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Zika Virus Infection Drug Report Years Considered
Figure 10. Global Zika Virus Infection Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Zika Virus Infection Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Zika Virus Infection Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Zika Virus Infection Drug Market Share by Regions (2022-2027)
Figure 14. Global Zika Virus Infection Drug Market Share by Players in 2020
Figure 15. Global Top Zika Virus Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zika Virus Infection Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Zika Virus Infection Drug Revenue in 2020
Figure 17. Global Zika Virus Infection Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Zika Virus Infection Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Zika Virus Infection Drug Market Share by Type (2016-2027)
Figure 21. North America Zika Virus Infection Drug Market Share by Application (2016-2027)
Figure 22. North America Zika Virus Infection Drug Market Share by Country (2016-2027)
Figure 23. United States Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Zika Virus Infection Drug Market Share by Type (2016-2027)
Figure 27. Europe Zika Virus Infection Drug Market Share by Application (2016-2027)
Figure 28. Europe Zika Virus Infection Drug Market Share by Country (2016-2027)
Figure 29. Germany Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Zika Virus Infection Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Zika Virus Infection Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Zika Virus Infection Drug Market Share by Region (2016-2027)
Figure 39. China Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Zika Virus Infection Drug Market Share by Type (2016-2027)
Figure 47. Latin America Zika Virus Infection Drug Market Share by Application (2016-2027)
Figure 48. Latin America Zika Virus Infection Drug Market Share by Country (2016-2027)
Figure 49. Mexico Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Zika Virus Infection Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Zika Virus Infection Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Zika Virus Infection Drug Market Share by Country (2016-2027)
Figure 55. Turkey Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Zika Virus Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Emergent BioSolutions Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 59. Valneva Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 60. Moderna Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 61. Novavax Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 63. Themis Bioscience Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 65. IMV Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 66. Takeda Pharmaceutical Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 67. CaroGen Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 68. GeoVax Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 69. Tychan Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 70. Inovio Pharmaceuticals Revenue Growth Rate in Zika Virus Infection Drug Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の腸内細菌科感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Enterobacteriaceae Infection Drug Market Size, Status and Forecast 2021-2027
QFJ1-4190 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、腸内細菌科感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベータラクタム薬剤、カルバペネム薬剤、フルオロキノロン薬剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地...

世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4533 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...

世界のロタウイルス感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Rotavirus Infection Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4839 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ロタウイルス感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年）

Global Sporothrix Schenckii Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4897 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、スポロトリクスシェンキー感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イトラコナゾール薬、アムホテリシンB薬、ヨウ化カリウム飽和溶液（SSKI）、手術、その他）、用途別市場規模（病院、専門...

世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年）

Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5991 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パリビズマブ、リバビリン、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、その他）、主要地域別市場規模...

世界のウエストナイルウイルス検査市場規模・現状・予測（2021年-2027年）

Global West Nile Virus Testing Market Size, Status and Forecast 2021-2027
QFJ1-5038 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウエストナイルウイルス検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、免疫組織検査、その他）、用途別市場規模（病院、血液銀行、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Clostridium Botulinum Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4028 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ボツリヌス菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素療法、細心気道管理、人工呼吸補助）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年）

Global Pediatric HIV Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児HIV感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（無症状、軽症、中症、重症）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、主要地域別市場規模（北米、...

世界のブドウ球菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Staphylococcal Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4899 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ブドウ球菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射液）、用途別市場規模（黄色ブドウ球菌感染症、表皮ブドウ球菌感染症、サプロコッカス感染症）、主要地域別市場規模（北米、アメ...

世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年）

Global Intra-amniotic Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5807 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、羊膜感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲンタマイシン、クリンダマイシン、メトロニダゾール、その他）、用途別市場規模（病院・専門クリニック、外来手術センター、病院薬局、小売薬局、...

ジカウイルスワクチンのグローバル市場調査 2019年 The global Zika Virus Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Zika Virus Vaccines volume and value at global level, regional level and company level. From a global perspective, this…
ジカウイルスワクチンのグローバル市場調査 2019年 The global Zika Virus Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Zika Virus Vaccines volume and value at global level, regional level and company level. From a global perspective, this…
世界の腸内細菌科感染症治療薬市場規模・現状・予測（2021年-2027年） Enterobacteriaceae infections are caused by Enterobacter species, pathogens responsible for causing severe infections including bacteremia, urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections. Market Analysis and Insights: Glo…
世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Syncytial Virus(RSV) Therapeutics Market The global Respiratory Syncytial Virus(RSV) Therapeutics market size is projected to reach US$ 837.5 million by 2027, from US$ 564.7 million in 2020, at a CAGR of 5.7% during 2021-2027. With industry-standard a…
世界のウエストナイルウイルス検査市場規模・現状・予測（2021年-2027年） West Nile virus is a tropical and temperate virus. It mainly infects birds, but also humans, horses, cats, skunks, gray rats, and domestic rabbits. The main route of transmission in humans is the bite of an infected mosquito. Market Analysis and Insights: Global West Nile Virus Testing Market The gl…